Arbecin IV Injection

Prophylaxis of uterine atony and excessive bleeding after caesarean section

Intravenous Prophylaxis of uterine atony and excessive bleeding after caesarean section Adult: Single dose of 100 mcg given over 1 min after delivery.

RENAL IMPAIRMENT avoid.

HEPATIC IMPAIRMENT avoid in hepatic disease.

Do not administer before delivery. Vascular disease esp coronary artery disease; hepatic or renal disease.

Monitor BP in eclampsia and preeclampsia for up to 8 hrs. Inadequate uterine contraction (do not repeat treatment). Epilepsy; migraine; asthma.

Not Classi Pregnancy Use of carbetocin injection is contraindicated during pregnancy. Use in lactation Small amounts of carbetocin has been shown to cross over from plasma into the breast milk of nursing women. The small amount of carbetocin ingested by infant would not be expected to present a significant safety concern.

Vasoconstrictors in conjunction with caudal block anaesthesia; cyclopropane anaesthesia.

Nausea; vomiting; abdominal pain; pruritus; flushing; feeling of warmth; hypotension; headache; tremor; back pain; dizziness; metallic taste; anaemia; sweating; chest pain; dyspnoea; chills; tachycardia; anxiety.

Carbetocin is a synthetic analogue of oxytocin reported to have a longer duration of action.

Arbecin IV 100 mcg/ml Injection manufactured by Renata PLC.. Its generic name is Carbetocin.